Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank83
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-178.72M
↑ 29% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-253.21M
Historical baseline
PeriodValueYoY Change
2025$-178.72M+53.2%
2024$-382.13M-13.6%
2023$-336.30M-10.5%
2022$-304.47M+1.9%
2021$-310.34M-60.3%
2020$-193.65M-189.5%
2019$-66.88M-